{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:19:35Z","timestamp":1792840775304,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Glutamine synthetase (GS) plays a crucial role in the homeostasis of the glutamate\u2013glutamine cycle in the brain. Hypoactive GS causes depressive behaviors. Under chronic stress, GS has no change in expression, but its activity is decreased due to nitration of tyrosine (Tyr). Thus, we speculate that agents that prevent nitration or facilitate denitration of GS would be candidates for new antidepressants. Using human recombinant GS and mouse lysate from the medial prefrontal cortex, we demonstrated that Tyr (0.0313\u22120.5\u2009\u00b5M) dose-dependently protected GS activity against peroxynitrite-induced Tyr-nitration of GS. Diet supplementation with Tyr exerted significant antidepressant effects in a chronic immobilization stress depression mouse model. We further found that dipeptides, such as tyrosyl-glutamine (YQ), that had appropriate chemical properties for medication also increased GS activity both in vitro and in vivo and exerted antidepressant effects. Because reduced GS activity also occurs in epilepsy and hyperammonemia, we evaluated whether Tyr and YQ had therapeutic effects. Interestingly, Tyr or YQ administration significantly attenuated kainic acid-induced seizures in mice and reduced blood ammonia levels in azoxymethane- or bile duct ligation-induced hyperammonemia mouse models, which was accompanied by an increment in GS activity. The activation of GS was accomplished by a decrement in Tyr-nitration, so-called Tyr-denitration. Therefore, this study demonstrates that the activation of GS could be a new strategy to treat depression and other GS-related diseases.<\/jats:p>","DOI":"10.1038\/s41401-024-01441-2","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T06:27:16Z","timestamp":1736231236000},"page":"880-891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Activation of glutamine synthetase (GS) as a new strategy for the treatment of major depressive disorder and other GS-related diseases"],"prefix":"10.1038","volume":"46","author":[{"given":"Jae Soon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwajin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hyeong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyoung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeongchan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonjune","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Young","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study C.","year":"2015","unstructured":"Global Burden of Disease Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743\u2013800.","journal-title":"Lancet"},{"key":"1441_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1176\/appi.ajp.158.5.735","volume":"158","author":"JG Keilp","year":"2001","unstructured":"Keilp JG, Sackeim HA, Brodsky BS, Oquendo MA, Malone KM, Mann JJ. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry. 2001;158:735\u201341.","journal-title":"Am J Psychiatry"},{"key":"1441_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32918-5","volume":"13","author":"R Kleine","year":"2023","unstructured":"Kleine R, Galimov A, Hanewinkel R, Unger J, Sussman S, Hansen J. Impact of the COVID-19 pandemic on young people with and without pre-existing mental health problems. Sci Rep. 2023;13:6111.","journal-title":"Sci Rep"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1073\/pnas.1118355109","volume":"109","author":"S Cohen","year":"2012","unstructured":"Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA. 2012;109:5995\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3389\/fonc.2020.01492","volume":"10","author":"S Dai","year":"2020","unstructured":"Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, et al. Chronic stress promotes cancer development. Front Oncol. 2020;10:1492.","journal-title":"Front Oncol"},{"key":"1441_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41574-022-00746-8","volume":"19","author":"M Kivimaki","year":"2023","unstructured":"Kivimaki M, Bartolomucci A, Kawachi I. The multiple roles of life stress in metabolic disorders. Nat Rev Endocrinol. 2023;19:10\u201327.","journal-title":"Nat Rev Endocrinol"},{"key":"1441_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s13679-011-0006-3","volume":"1","author":"KA Scott","year":"2012","unstructured":"Scott KA, Melhorn SJ, Sakai RR. Effects of chronic social stress on obesity. Curr Obes Rep. 2012;1:16\u201325.","journal-title":"Curr Obes Rep"},{"key":"1441_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nrcardio.2012.45","volume":"9","author":"A Steptoe","year":"2012","unstructured":"Steptoe A, Kivimaki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012;9:360\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"1441_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/archpsyc.1986.01800040015003","volume":"43","author":"N Breslau","year":"1986","unstructured":"Breslau N, Davis GC. Chronic stress and major depression. Arch Gen Psychiatry. 1986;43:309\u201314.","journal-title":"Arch Gen Psychiatry"},{"key":"1441_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/7854_2010_108","volume":"7","author":"V Krishnan","year":"2011","unstructured":"Krishnan V, Nestler EJ. Animal models of depression: molecular perspectives. Curr Top Behav Neurosci. 2011;7:121\u201347.","journal-title":"Curr Top Behav Neurosci"},{"key":"1441_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2017.04.008","volume":"77","author":"Q Wang","year":"2017","unstructured":"Wang Q, Timberlake MA 2nd, Prall K, Dwivedi Y. The recent progress in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2017;77:99\u2013109.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1441_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2009.06.025","volume":"461","author":"Y Joo","year":"2009","unstructured":"Joo Y, Choi KM, Lee YH, Kim G, Lee DH, Roh GS, et al. Chronic immobilization stress induces anxiety- and depression-like behaviors and decreases transthyretin in the mouse cortex. Neurosci Lett. 2009;461:121\u20135.","journal-title":"Neurosci Lett"},{"key":"1441_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-13-58","volume":"13","author":"S Jung","year":"2012","unstructured":"Jung S, Lee Y, Kim G, Son H, Lee DH, Roh GS, et al. Decreased expression of extracellular matrix proteins and trophic factors in the amygdala complex of depressed mice after chronic immobilization stress. BMC Neurosci. 2012;13:58.","journal-title":"BMC Neurosci"},{"key":"1441_CR14","doi-asserted-by":"publisher","unstructured":"Son H, Yang JH, Kim HJ, Lee DK. A chronic immobilization stress protocol for inducing depression-like behavior in mice. J Vis Exp. 2019. https:\/\/doi.org\/10.3791\/59546.","DOI":"10.3791\/59546"},{"key":"1441_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1503\/jpn.120024","volume":"38","author":"Y Lee","year":"2013","unstructured":"Lee Y, Son H, Kim G, Kim S, Lee DH, Roh GS, et al. Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice. J Psychiatry Neurosci. 2013;38:183\u201391.","journal-title":"J Psychiatry Neurosci"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.09.040","volume":"143","author":"H Son","year":"2018","unstructured":"Son H, Baek JH, Go BS, Jung DH, Sontakke SB, Chung HJ, et al. Glutamine has antidepressive effects through increments of glutamate and glutamine levels and glutamatergic activity in the medial prefrontal cortex. Neuropharmacology. 2018;143:143\u201352.","journal-title":"Neuropharmacology"},{"key":"1441_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","volume":"102","author":"RS Duman","year":"2019","unstructured":"Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102:75\u201390.","journal-title":"Neuron"},{"key":"1441_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1196\/annals.1300.016","volume":"1003","author":"IA Paul","year":"2003","unstructured":"Paul IA, Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci. 2003;1003:250\u201372.","journal-title":"Ann N Y Acad Sci"},{"key":"1441_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.8","volume":"6","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto K, Bruno D, Nierenberg J, Marmar CR, Zetterberg H, Blennow K, et al. Abnormality in glutamine\u2013glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study. Transl Psychiatry. 2016;6:e744.","journal-title":"Transl Psychiatry"},{"key":"1441_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1038\/s41386-018-0136-3","volume":"43","author":"CG Abdallah","year":"2018","unstructured":"Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, et al. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018;43:2154\u201360.","journal-title":"Neuropsychopharmacology"},{"key":"1441_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","volume":"24","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24:952\u201364.","journal-title":"Mol Psychiatry"},{"key":"1441_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.biopsych.2013.09.024","volume":"76","author":"P Veeraiah","year":"2014","unstructured":"Veeraiah P, Noronha JM, Maitra S, Bagga P, Khandelwal N, Chakravarty S, et al. Dysfunctional glutamatergic and gamma-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression. Biol Psychiatry. 2014;76:231\u20138.","journal-title":"Biol Psychiatry"},{"key":"1441_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1001\/archgenpsychiatry.2009.39","volume":"66","author":"M Walter","year":"2009","unstructured":"Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, et al. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch Gen Psychiatry. 2009;66:478\u201386.","journal-title":"Arch Gen Psychiatry"},{"key":"1441_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jpsychires.2016.06.017","volume":"82","author":"J Zhao","year":"2016","unstructured":"Zhao J, Verwer RW, van Wamelen DJ, Qi XR, Gao SF, Lucassen PJ, et al. Prefrontal changes in the glutamate-glutamine cycle and neuronal\/glial glutamate transporters in depression with and without suicide. J Psychiatr Res. 2016;82:8\u201315.","journal-title":"J Psychiatr Res"},{"key":"1441_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14737175.2019.1640604","volume":"19","author":"J Swainson","year":"2019","unstructured":"Swainson J, Thomas RK, Archer S, Chrenek C, MacKay MA, Baker G, et al. Esketamine for treatment resistant depression. Expert Rev Neurother. 2019;19:899\u2013911.","journal-title":"Expert Rev Neurother"},{"key":"1441_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/etm.2023.11810","volume":"25","author":"O Vasiliu","year":"2023","unstructured":"Vasiliu O. Esketamine for treatment\u2011resistant depression: a review of clinical evidence (Review). Exp Ther Med. 2023;25:111.","journal-title":"Exp Ther Med"},{"key":"1441_CR27","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.1073\/pnas.0507901102","volume":"102","author":"PV Choudary","year":"2005","unstructured":"Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, BVawter MP, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA. 2005;102:15653\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1441_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1111\/j.1528-1167.2008.01642.x","volume":"49","author":"HJ Bidmon","year":"2008","unstructured":"Bidmon HJ, Gorg B, Palomero-Gallagher N, Schleicher A, Haussinger D, Speckmann EJ, et al. Glutamine synthetase becomes nitrated and its activity is reduced during repetitive seizure activity in the pentylentetrazole model of epilepsy. Epilepsia. 2008;49:1733\u201348.","journal-title":"Epilepsia"},{"key":"1441_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.febslet.2006.11.081","volume":"581","author":"B Gorg","year":"2007","unstructured":"Gorg B, Qvartskhava N, Voss P, Grune T, Haussinger D, Schliess F. Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Lett. 2007;581:84\u201390.","journal-title":"FEBS Lett"},{"key":"1441_CR30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/ar300234c","volume":"46","author":"R Radi","year":"2013","unstructured":"Radi R. Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects. Acc Chem Res. 2013;46:550\u20139.","journal-title":"Acc Chem Res"},{"key":"1441_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1046\/j.1471-4159.2000.740785.x","volume":"74","author":"R Olivenza","year":"2000","unstructured":"Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J, et al. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem. 2000;74:785\u201391.","journal-title":"J Neurochem"},{"key":"1441_CR32","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/antiox10091439","volume":"10","author":"G Juszczyk","year":"2021","unstructured":"Juszczyk G, Mikulska J, Kasperek K, Pietrzak D, Mrozek W, Herbet M. Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer\u2019s disease: the role of antioxidants in prevention and treatment. Antioxidants. 2021;10:1439.","journal-title":"Antioxidants"},{"key":"1441_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/hep.28852","volume":"65","author":"TB Hakvoort","year":"2017","unstructured":"Hakvoort TB, He Y, Kulik W, Vermeulen JL, Duijst S, Ruijter JM, et al. Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology. 2017;65:281\u201393.","journal-title":"Hepatology"},{"key":"1441_CR34","doi-asserted-by":"crossref","unstructured":"Baek JH, Jung S, Son H, Kang JS, Kim HJ. Glutamine supplementation prevents chronic stress-induced mild cognitive impairment. Nutrients. 2020;12:910.","DOI":"10.3390\/nu12040910"},{"key":"1441_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1874609810666170315112634","volume":"10","author":"B Chakravarti","year":"2017","unstructured":"Chakravarti B, Chakravarti DN. Protein tyrosine nitration: role in aging. Curr Aging Sci. 2017;10:246\u201362.","journal-title":"Curr Aging Sci"},{"key":"1441_CR36","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1021\/acs.jctc.0c00249","volume":"16","author":"B Frieg","year":"2020","unstructured":"Frieg B, Gorg B, Qvartskhava N, Jeitner T, Homeyer N, Haussinger D, et al. Mechanism of fully reversible, pH-sensitive inhibition of human glutamine synthetase by tyrosine nitration. J Chem Theory Comput. 2020;16:4694\u2013705.","journal-title":"J Chem Theory Comput"},{"key":"1441_CR37","doi-asserted-by":"crossref","unstructured":"Son H, Jung S, Shin JH, Kang MJ, Kim HJ. Anti-stress and anti-depressive effects of spinach extracts on a chronic stress-induced depression mouse model through lowering blood corticosterone and increasing brain glutamate and glutamine levels. J Clin Med. 2018;7:406.","DOI":"10.3390\/jcm7110406"},{"key":"1441_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-0327(90)90017-3","volume":"19","author":"AJ Gelenberg","year":"1990","unstructured":"Gelenberg AJ, Wojcik JD, Falk WE, Baldessarini RJ, Zeisel SH, Schoenfeld D, et al. Tyrosine for depression: a double-blind trial. J Affect Disord. 1990;19:125\u201332.","journal-title":"J Affect Disord"},{"key":"1441_CR39","first-page":"224","volume":"32","author":"SN Young","year":"2007","unstructured":"Young SN. L-tyrosine to alleviate the effects of stress? J Psychiatry Neurosci. 2007;32:224.","journal-title":"J Psychiatry Neurosci"},{"key":"1441_CR40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62:63\u201377.","journal-title":"Neuropharmacology"},{"key":"1441_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF01579067","volume":"43","author":"A Carlsson","year":"1978","unstructured":"Carlsson A, Lindqvist M. Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm. 1978;43:73\u201391.","journal-title":"J Neural Transm"},{"key":"1441_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0006-2952(77)90057-0","volume":"26","author":"CJ Gibson","year":"1977","unstructured":"Gibson CJ, Wurtman RJ. Physiological control of brain catechol synthesis by brain tyrosine concentration. Biochem Pharmacol. 1977;26:1137\u201342.","journal-title":"Biochem Pharmacol"},{"key":"1441_CR43","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/BF02623607","volume":"24","author":"E Roth","year":"1988","unstructured":"Roth E, Ollenschlager G, Hamilton G, Simmel A, Langer K, Fekl W, et al. Influence of two glutamine-containing dipeptides on growth of mammalian cells. Vitr Cell Dev Biol. 1988;24:696\u20138.","journal-title":"Vitr Cell Dev Biol"},{"key":"1441_CR44","first-page":"923","volume":"21","author":"W Druml","year":"1995","unstructured":"Druml W, Hubl W, Roth E, Lochs H. Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure. Hepatology. 1995;21:923\u20138.","journal-title":"Hepatology"},{"key":"1441_CR45","doi-asserted-by":"publisher","first-page":"2562S","DOI":"10.1093\/jn\/131.9.2562S","volume":"131","author":"P Furst","year":"2001","unstructured":"Furst P. New developments in glutamine delivery. J Nutr. 2001;131:2562S\u20138S.","journal-title":"J Nutr"},{"key":"1441_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0899-9007(00)00321-X","volume":"16","author":"P Furst","year":"2000","unstructured":"Furst P, Kuhn KS. Amino-acid substrates in new bottles: implications for clinical nutrition in the 21st century. Nutrition. 2000;16:603\u20136.","journal-title":"Nutrition"},{"key":"1441_CR47","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/011542659300800395","volume":"8","author":"JA Vazquez","year":"1993","unstructured":"Vazquez JA, Daniel H, Adibi SA. Dipeptides in parenteral nutrition: from basic science to clinical applications. Nutr Clin Pr. 1993;8:95\u2013105.","journal-title":"Nutr Clin Pr"},{"key":"1441_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5607\/en.2019.28.2.270","volume":"28","author":"JH Baek","year":"2019","unstructured":"Baek JH, Vignesh A, Son H, Lee DH, Roh GS, Kang SS, et al. Glutamine supplementation ameliorates chronic stress-induced reductions in glutamate and glutamine transporters in the mouse prefrontal cortex. Exp Neurobiol. 2019;28:270\u20138.","journal-title":"Exp Neurobiol"},{"key":"1441_CR49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0006-8993(98)00863-4","volume":"810","author":"RQ Hu","year":"1998","unstructured":"Hu RQ, Koh S, Torgerson T, Cole AJ. Neuronal stress and injury in C57\/BL mice after systemic kainic acid administration. Brain Res. 1998;810:229\u201340.","journal-title":"Brain Res"},{"key":"1441_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0140-6736(03)15166-5","volume":"363","author":"T Eid","year":"2004","unstructured":"Eid T, Thomas MJ, Spencer DD, Rund\u00e9n-Pran E, Lai JC, Malthankar GV, et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet. 2004;363:28\u201337.","journal-title":"Lancet"},{"key":"1441_CR51","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s11064-012-0766-5","volume":"37","author":"T Eid","year":"2012","unstructured":"Eid T, Behar K, Dhaher R, Bumanglag AV, Lee TS. Roles of glutamine synthetase inhibition in epilepsy. Neurochem Res. 2012;37:2339\u201350.","journal-title":"Neurochem Res"},{"key":"1441_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/0972-2327.138471","volume":"17","author":"S Sharma","year":"2014","unstructured":"Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann Indian Acad Neurol. 2014;17:253\u20138.","journal-title":"Ann Indian Acad Neurol"},{"key":"1441_CR53","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1515\/hsz-2021-0166","volume":"402","author":"B Frieg","year":"2021","unstructured":"Frieg B, Gorg B, Gohlke H, Haussinger D. Glutamine synthetase as a central element in hepatic glutamine and ammonia metabolism: novel aspects. Biol Chem. 2021;402:1063\u201372.","journal-title":"Biol Chem"},{"key":"1441_CR54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/jimd.12070","volume":"42","author":"LR Soria","year":"2019","unstructured":"Soria LR, Nitzahn M, De Angelis A, Khoja S, Attanasio S, Annunziata P, et al. Hepatic glutamine synthetase augmentation enhances ammonia detoxification. J Inherit Metab Dis. 2019;42:1128\u201335.","journal-title":"J Inherit Metab Dis"},{"key":"1441_CR55","first-page":"765","volume":"76","author":"A Desmouliere","year":"1997","unstructured":"Desmouliere A, Darby I, Costa AM, Raccurt M, Tuchweber B, Sommer P, et al. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest. 1997;76:765\u201378.","journal-title":"Lab Invest"},{"key":"1441_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.17085\/apm.2020.15.1.19","volume":"15","author":"I Cho","year":"2020","unstructured":"Cho I, Koo BN, Kam EH, Lee SK, Oh H, Kim SY. Bile duct ligation of C57BL\/6 mice as a model of hepatic encephalopathy. Anesth Pain Med. 2020;15:19\u201327.","journal-title":"Anesth Pain Med"},{"key":"1441_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22423-6","volume":"12","author":"W Claeys","year":"2022","unstructured":"Claeys W, Van Hoecke L, Geerts A, Van Vlierberghe H, Lefere S, Van Imschoot G, et al. A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation. Sci Rep. 2022;12:17558.","journal-title":"Sci Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01441-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01441-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:08:48Z","timestamp":1743350928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-024-01441-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1038\/s41401-024-01441-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}